{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:18:48Z","timestamp":1775780328634,"version":"3.50.1"},"reference-count":39,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,9,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A 3-1\/2-year-old male with no personal or family history of bleeding disorders presented with abdominal distension, epistaxis, and anemia (hemoglobin 8.2 g\/dL). A magnetic resonance imaging scan of the abdomen demonstrated a mass arising from the left kidney. Preoperative laboratory studies revealed a prolonged activated partial thromboplastin time of 49.2 seconds, a normal prothrombin time of 12.4 seconds, and a platelet count of 230\u2009000\/\u03bcL. Further testing revealed factor VIII (FVIII) activity of 16%, factor IX (FIX) activity of 74%, von Willebrand factor (VWF) activity of 12%, VWF antigen activity of 31%, and decreased high-molecular-weight VWF multimers consistent with acquired von Willebrand syndrome (AVWS). What is the best treatment for this child?<\/jats:p>","DOI":"10.1182\/blood-2012-10-435719","type":"journal-article","created":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T23:52:15Z","timestamp":1374537135000},"page":"2019-2022","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":28,"title":["Treatment of acquired von Willebrand syndrome in childhood"],"prefix":"10.1182","volume":"122","author":[{"given":"Michael U.","family":"Callaghan","sequence":"first","affiliation":[{"name":"Wayne State University and Children\u2019s Hospital of Michigan, Detroit, MI;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trisha E.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, Seattle Children\u2019s Hospital, Seattle, WA;"},{"name":"Department of Pediatrics, University of Washington, Seattle, WA;"},{"name":"Puget Sound Blood Center, Seattle, WA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto B.","family":"Federici","sequence":"additional","affiliation":[{"name":"Division of Hematology and Transfusion Medicine, L. Sacco University Hospital, Department of Clinical Sciences & Community Health, Universita\u2019 degli Studi di Milano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"2 Suppl","key":"2019111817094514700_B1","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1378\/chest.11-2288","article-title":"Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"issue":"2","key":"2019111817094514700_B2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand\u2019s disease.","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"issue":"4","key":"2019111817094514700_B3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.10298","article-title":"Acquired von Willebrand\u2019s syndrome: a single institution experience.","volume":"72","author":"Kumar","year":"2003","journal-title":"Am J Hematol"},{"key":"2019111817094514700_B4","doi-asserted-by":"crossref","article-title":"Acquired von Willebrand syndrome: is it an extremely rare disorder or do we see only the tip of the iceberg?","author":"Federici","DOI":"10.1111\/j.1538-7836.2008.02917.x"},{"issue":"2-3","key":"2019111817094514700_B5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000214858","article-title":"Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies.","volume":"121","author":"Sucker","year":"2009","journal-title":"Acta Haematol"},{"issue":"25","key":"2019111817094514700_B6","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","article-title":"How I treat the acquired von Willebrand syndrome.","volume":"117","author":"Tiede","year":"2011","journal-title":"Blood"},{"issue":"8","key":"2019111817094514700_B7","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood.V92.8.2707","article-title":"Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches.","volume":"92","author":"Federici","year":"1998","journal-title":"Blood"},{"issue":"2","key":"2019111817094514700_B8","first-page":"345","article-title":"Acquired von Willebrand syndrome: data from an international registry.","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemost"},{"issue":"6","key":"2019111817094514700_B9","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V31.6.806.806","article-title":"Acquired von Willebrand\u2019s syndrome in systemic lupus erythematosus.","volume":"31","author":"Simone","year":"1968","journal-title":"Blood"},{"issue":"1","key":"2019111817094514700_B10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00043426-198921000-00008","article-title":"Acquired von Willebrand\u2019s syndrome with lupus-like serology.","volume":"11","author":"Igarashi","year":"1989","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"2019111817094514700_B11","author":"Niiya"},{"issue":"3","key":"2019111817094514700_B12","first-page":"424","article-title":"Autoantibody to von Willebrand factor in systemic lupus erythematosus.","volume":"121","author":"Soff","year":"1993","journal-title":"J Lab Clin Med"},{"issue":"10","key":"2019111817094514700_B13","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1182\/blood.V91.10.3623","article-title":"Clinical significance of inhibitors in acquired von Willebrand syndrome.","volume":"91","author":"Mohri","year":"1998","journal-title":"Blood"},{"key":"2019111817094514700_B14","author":"Coppes"},{"issue":"4","key":"2019111817094514700_B15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1182\/blood.V58.4.665.bloodjournal584665","article-title":"Acquired von Willebrand\u2019s disease in association with Wilm\u2019s tumor: regression following treatment.","volume":"58","author":"Scott","year":"1981","journal-title":"Blood"},{"issue":"6","key":"2019111817094514700_B16","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0022-3476(79)80293-0","article-title":"Acquired von Willebrand disease in a patient with Wilms tumor.","volume":"95","author":"Noronha","year":"1979","journal-title":"J Pediatr"},{"key":"2019111817094514700_B17","author":"Will"},{"key":"2019111817094514700_B18","author":"Michiels"},{"issue":"1","key":"2019111817094514700_B19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0030-1270069","article-title":"Acquired von Willebrand syndrome associated with hypothyroidism: a mild bleeding disorder to be further investigated.","volume":"37","author":"Federici","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"2019111817094514700_B20","author":"Manfredi"},{"key":"2019111817094514700_B21","author":"Galli-Tsinopoulou"},{"issue":"8540","key":"2019111817094514700_B22","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(87)92272-0","article-title":"Hypothyroidism as a cause of acquired von Willebrand\u2019s disease.","volume":"1","author":"Dalton","year":"1987","journal-title":"Lancet"},{"issue":"4","key":"2019111817094514700_B23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1055\/s-0038-1646064","article-title":"Acquired von Willebrand\u2019s disease in hypothyroidism.","volume":"58","author":"Takahashi","year":"1987","journal-title":"Thromb Haemost"},{"issue":"9","key":"2019111817094514700_B24","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1515\/jpem.2010.155","article-title":"Investigation of acquired von Willebrand Syndrome in children with hypothyroidism: reversal after treatment with thyroxine.","volume":"23","author":"Olukman","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"2019111817094514700_B25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0037-1616250","article-title":"Analysis of thyroid hormone status in 131 consecutive individuals with low von Willebrand factor levels.","volume":"93","author":"Franchini","year":"2005","journal-title":"Thromb Haemost"},{"issue":"1","key":"2019111817094514700_B26","first-page":"58","article-title":"von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding.","volume":"106","author":"Casonato","year":"2011","journal-title":"Thromb Haemost"},{"issue":"3","key":"2019111817094514700_B27","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V67.3.758.758","article-title":"Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects.","volume":"67","author":"Gill","year":"1986","journal-title":"Blood"},{"issue":"5","key":"2019111817094514700_B28","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/j.thromres.2012.08.314","article-title":"Bleeding diathesis in Noonan syndrome: Is acquired von Willebrand syndrome the clue?","volume":"130","author":"Wiegand","year":"2012","journal-title":"Thromb Res"},{"issue":"1","key":"2019111817094514700_B29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/heart.88.1.87","article-title":"Acquired von Willebrand syndrome in children with patent ductus arteriosus.","volume":"88","author":"Rauch","year":"2002","journal-title":"Heart"},{"issue":"4","key":"2019111817094514700_B30","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.athoracsur.2010.12.013","article-title":"First experiences with the HeartWare ventricular assist system in children.","volume":"91","author":"Miera","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"2019111817094514700_B31","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2011.08732.x","article-title":"Acquired von Willebrand Syndrome in congenital heart disease: does it promote an increased bleeding risk?","volume":"155","author":"Onimoe","year":"2011","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111817094514700_B32","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.athoracsur.2011.01.052","article-title":"Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion.","volume":"91","author":"Steinlechner","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"2019111817094514700_B33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/beha.2001.0141","article-title":"Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.","volume":"14","author":"Michiels","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"2019111817094514700_B34","author":"Koenig"},{"issue":"1","key":"2019111817094514700_B35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/088307380201700110","article-title":"Coagulation abnormalities and acquired von Willebrand\u2019s disease type 1 in children receiving valproic acid.","volume":"17","author":"Serdaroglu","year":"2002","journal-title":"J Child Neurol"},{"issue":"1","key":"2019111817094514700_B36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00043426-200001000-00012","article-title":"Hematologic toxicity of sodium valproate.","volume":"22","author":"Acharya","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"issue":"8701","key":"2019111817094514700_B37","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/0140-6736(90)91235-3","article-title":"Induction of von Willebrand disease type I by valproic acid.","volume":"335","author":"Kreuz","year":"1990","journal-title":"Lancet"},{"issue":"1","key":"2019111817094514700_B38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1528-1157.1992.tb02303.x","article-title":"Valproate therapy induces von Willebrand disease type I.","volume":"33","author":"Kreuz","year":"1992","journal-title":"Epilepsia"},{"issue":"2","key":"2019111817094514700_B39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-0037-1617026","article-title":"Acquired von Willebrand syndrome as side effect of valproic acid therapy in children is rare.","volume":"29","author":"Eberl","year":"2009","journal-title":"Hamostaseologie"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/122\/12\/2019\/1369078\/2019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/122\/12\/2019\/1369078\/2019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T17:10:12Z","timestamp":1574097012000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/122\/12\/2019\/31664\/Treatment-of-acquired-von-Willebrand-syndrome-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,19]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,9,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-10-435719","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,19]]}}}